Logo image of PTRA

PROTERRA INC (PTRA) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:PTRA - US74374T1097 - Common Stock

0.067 USD
-0.02 (-25.56%)
Last: 8/16/2023, 8:17:12 PM
0.065 USD
0 (-2.99%)
After Hours: 8/16/2023, 8:17:12 PM
Fundamental Rating

2

Taking everything into account, PTRA scores 2 out of 10 in our fundamental rating. PTRA was compared to 132 industry peers in the Machinery industry. Both the profitability and financial health of PTRA have multiple concerns. PTRA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • PTRA had negative earnings in the past year.
  • PTRA had a negative operating cash flow in the past year.
PTRA Yearly Net Income VS EBIT VS OCF VS FCFPTRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 -100M -200M -300M

1.2 Ratios

  • PTRA has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PTRA Yearly ROA, ROE, ROICPTRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 -10 -20 -30 -40

1.3 Margins

  • PTRA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PTRA Yearly Profit, Operating, Gross MarginsPTRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 0 -20 -40 -60 -80 -100

More info and screens

2

2. Health

2.1 Basic Checks

  • PTRA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for PTRA has been increased compared to 1 year ago.
  • Compared to 1 year ago, PTRA has a worse debt to assets ratio.
PTRA Yearly Shares OutstandingPTRA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 50M 100M 150M 200M
PTRA Yearly Total Debt VS Total AssetsPTRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 200M 400M 600M 800M

2.2 Solvency

  • PTRA has an Altman-Z score of -2.67. This is a bad value and indicates that PTRA is not financially healthy and even has some risk of bankruptcy.
  • PTRA has a Altman-Z score of -2.67. This is amonst the worse of the industry: PTRA underperforms 90.63% of its industry peers.
  • A Debt/Equity ratio of 0.00 indicates that PTRA is not too dependend on debt financing.
  • PTRA has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. PTRA outperforms 85.94% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.67
ROIC/WACCN/A
WACC6.89%
PTRA Yearly LT Debt VS Equity VS FCFPTRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 0 200M -200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 1.39 indicates that PTRA should not have too much problems paying its short term obligations.
  • The Current ratio of PTRA (1.39) is worse than 82.03% of its industry peers.
  • PTRA has a Quick Ratio of 1.39. This is a bad value and indicates that PTRA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • PTRA has a Quick ratio of 0.76. This is amonst the worse of the industry: PTRA underperforms 81.25% of its industry peers.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 0.76
PTRA Yearly Current Assets VS Current LiabilitesPTRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 200M 400M 600M 800M

More info and screens

4

3. Growth

3.1 Past

  • The earnings per share for PTRA have decreased strongly by -194.37% in the last year.
  • The Revenue has grown by 29.59% in the past year. This is a very strong growth!
EPS 1Y (TTM)-194.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.04%
Revenue 1Y (TTM)29.59%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%14.95%

3.2 Future

  • The Earnings Per Share is expected to grow by 20.03% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 46.82% on average over the next years. This is a very strong growth
EPS Next Y-20.84%
EPS Next 2Y29.75%
EPS Next 3Y25.51%
EPS Next 5Y20.03%
Revenue Next Year47.51%
Revenue Next 2Y52.46%
Revenue Next 3Y59.79%
Revenue Next 5Y46.82%

3.3 Evolution

PTRA Yearly Revenue VS EstimatesPTRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
PTRA Yearly EPS VS EstimatesPTRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 -1 -1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for PTRA. In the last year negative earnings were reported.
  • Also next year PTRA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PTRA Price Earnings VS Forward Price EarningsPTRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PTRA Per share dataPTRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

  • PTRA's earnings are expected to grow with 25.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.75%
EPS Next 3Y25.51%

More info and screens

0

5. Dividend

5.1 Amount

  • PTRA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PROTERRA INC

NASDAQ:PTRA (8/16/2023, 8:17:12 PM)

After market: 0.065 0 (-2.99%)

0.067

-0.02 (-25.56%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)08-09
Earnings (Next)N/A
Inst Owners0.16%
Inst Owner Change0%
Ins Owners60.57%
Ins Owner Change0%
Market Cap15.26M
Revenue(TTM)341.46M
Net Income(TTM)-421.02M
Analysts78.33
Price Target3.73 (5467.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-295.67%
Min EPS beat(2)-295.67%
Max EPS beat(2)-295.67%
EPS beat(4)0
Avg EPS beat(4)-166.66%
Min EPS beat(4)-295.67%
Max EPS beat(4)-98.78%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-10.08%
Min Revenue beat(2)-10.19%
Max Revenue beat(2)-9.97%
Revenue beat(4)1
Avg Revenue beat(4)-3.32%
Min Revenue beat(4)-10.19%
Max Revenue beat(4)16.56%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-12.75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.58%
EPS NY rev (1m)0%
EPS NY rev (3m)-88.72%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)7.93%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.56%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.04
P/FCF N/A
P/OCF N/A
P/B 0.06
P/tB 0.06
EV/EBITDA N/A
EPS(TTM)-1.37
EYN/A
EPS(NY)-0.43
Fwd EYN/A
FCF(TTM)-1.27
FCFYN/A
OCF(TTM)-1.09
OCFYN/A
SpS1.5
BVpS1.17
TBVpS1.17
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 265.8%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.39
Quick Ratio 0.76
Altman-Z -2.67
F-Score3
WACC6.89%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-194.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.04%
EPS Next Y-20.84%
EPS Next 2Y29.75%
EPS Next 3Y25.51%
EPS Next 5Y20.03%
Revenue 1Y (TTM)29.59%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%14.95%
Revenue Next Year47.51%
Revenue Next 2Y52.46%
Revenue Next 3Y59.79%
Revenue Next 5Y46.82%
EBIT growth 1Y-59.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year24.14%
EBIT Next 3Y35.23%
EBIT Next 5Y26.57%
FCF growth 1Y-137.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-134.92%
OCF growth 3YN/A
OCF growth 5YN/A

PROTERRA INC / PTRA FAQ

What is the fundamental rating for PTRA stock?

ChartMill assigns a fundamental rating of 2 / 10 to PTRA.


Can you provide the valuation status for PROTERRA INC?

ChartMill assigns a valuation rating of 1 / 10 to PROTERRA INC (PTRA). This can be considered as Overvalued.


How profitable is PROTERRA INC (PTRA) stock?

PROTERRA INC (PTRA) has a profitability rating of 0 / 10.


Can you provide the financial health for PTRA stock?

The financial health rating of PROTERRA INC (PTRA) is 2 / 10.